brimonidine tartrate has been researched along with Encephalopathy, Toxic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cimolai, N | 1 |
| Aihara, M; Araie, M; Chen, YN; Lee, KY; Nakayama, M | 1 |
| Heimann, K; Hoernchen, H; Merz, U; Peschgens, T; Wenzl, T | 1 |
1 review(s) available for brimonidine tartrate and Encephalopathy, Toxic
| Article | Year |
|---|---|
A review of neuropsychiatric adverse events from topical ophthalmic brimonidine.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Antihypertensive Agents; Brimonidine Tartrate; Central Nervous System; Humans; Neurotoxicity Syndromes; Ophthalmic Solutions | 2020 |
2 other study(ies) available for brimonidine tartrate and Encephalopathy, Toxic
| Article | Year |
|---|---|
Brimonidine is neuroprotective against glutamate-induced neurotoxicity, oxidative stress, and hypoxia in purified rat retinal ganglion cells.
Topics: Animals; Brimonidine Tartrate; Cell Hypoxia; Cell Separation; Cell Survival; Glutamic Acid; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; Quinoxalines; Rats; Rats, Wistar; Retinal Ganglion Cells | 2010 |
[Depression of respiration via toxic effects on the central nervous system following use of topical brimonidine in an infant with congenital glaucoma].
Topics: Antihypertensive Agents; Apnea; Brimonidine Tartrate; Cataract; Female; Glaucoma; Humans; Infant, Newborn; Infant, Premature, Diseases; Neurotoxicity Syndromes; Ophthalmic Solutions; Postoperative Complications; Quinoxalines; Respiratory Insufficiency; Trabeculectomy | 2007 |